Search

Steve Bilodeau

from Cambridge, MA
Age ~41

Steve Bilodeau Phones & Addresses

  • 204 Lake View Ave, Cambridge, MA 02138

Industries

Biotechnology

Resumes

Resumes

Steve Bilodeau Photo 1

Postoctoral Fellow At Whitehead Institute

View page
Location:
Greater Boston Area
Industry:
Biotechnology

Publications

Us Patents

Compositions And Methods For Enhancing Cell Reprogramming

View page
US Patent:
2012003, Feb 9, 2012
Filed:
Sep 21, 2009
Appl. No.:
13/119891
Inventors:
Richard A. Young - Weston MA,
Steve Bilodeau - Cambridge MA,
Michael H. Kagey - Somerville MA,
International Classification:
A61K 35/12
C40B 30/06
C12N 5/10
C12N 5/071
C12Q 1/68
US Classification:
424 937, 435375, 435377, 435366, 435 61, 435 613, 506 10
Abstract:
The invention provides compositions and methods of use to enhance reprogramming of mammalian cells. Certain compositions and methods of the invention are of use to enhance generation of induced pluripotent stem cells by reprogramming somatic cells. Certain compositions and methods of the invention are of use to enhance reprogramming of pluripotent mammalian cells to a differentiated cell type. Certain compositions and methods of the invention are of use to enhance reprogramming of differentiated mammalian cells of a first cell type to differentiated mammalian cells of a second differentiated cell type. The reprogrammed somatic cells are useful for a number of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that enhances or contributes to reprogramming mammalian cells. Certain of the inventive compositions and methods relate to inhibiting histone methylation.

Mediator And Cohesin Connect Gene Expression And Chromatin Architecture

View page
US Patent:
2013010, May 2, 2013
Filed:
Feb 9, 2011
Appl. No.:
13/578114
Inventors:
Richard A. Young - Weston MA,
Jamie J. Newman - Cambridge MA,
Michael H. Kagey - Somerville MA,
Steve Bilodeau - Cambridge MA,
International Classification:
C12Q 1/68
C12N 9/96
US Classification:
514 44 A, 506 9, 435 612, 435 619, 435 613, 435188, 435 74, 435375
Abstract:
In some aspects, the present invention provides compositions and methods relating at least in part to modulation of the Cohesin-Mediator interaction. The invention provides compositions and methods useful for modulating Cohesin-Mediator function. The invention further provides compositions and methods useful for identifying compounds that modulate Cohesin-Mediator function. In some aspects, the invention provides compositions and methods useful for treating a disorder involving altered Cohesin-Mediator function.
Steve Bilodeau from Cambridge, MA, age ~41 Get Report